Outcomes in pediatric relapsed/refractory anaplastic large cell lymphoma: A multi-institutional retrospective analysis

被引:0
|
作者
Marks, Lianna Jean
Ritter, Victor
Schultz, Liora M.
Lowe, Eric J.
Aftandilian, Catherine
机构
[1] Stanford Univ, Sch Med, Palo Alto, CA USA
[2] Childrens Hosp Kings Daughters Surg Grp, Norfolk, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10032
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma
    John, Tami D.
    Naik, Swati
    Leung, Kathryn
    Sasa, Ghadir
    Martinez, Caridad
    Krance, Robert A.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (05)
  • [32] Allogeneic Hematopoietic Cell Transplant Following Crizotinib Monotherapy for Relapsed/Refractory Anaplastic Large Cell Lymphoma
    John, Tami
    Sasa, Ghadir
    Gottschalk, Stephen
    Ahmed, Nabil
    Allen, Carl
    Omer, Bilal
    Hegde, Meena
    Naik, Swati
    Leung, Kathryn
    Martinez, Caridad
    Krance, Robert A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S281 - S281
  • [33] BRENTUXIMAB VEDOTIN DESENSITIZATION IN A FEMALE WITH RELAPSED, REFRACTORY, ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
    Qamar, N.
    Cho, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A68 - A68
  • [34] Cost-effectiveness of brentuximab vedotin in relapsed or refractory systemic anaplastic large cell lymphoma
    Hux, Margaret
    Zou, Denise
    Ma, Esprit
    Sajosi, Peter
    Engstrom, Andreas
    Selby, Ross
    Benson, Eugene
    Teasell, Jeremy
    Richhariya, Akshara
    Briggs, Andrew
    Bonthapally, Vijayveer
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [35] Brentuximab vedotin: treatment role for relapsed refractory systemic anaplastic large-cell lymphoma
    Lai, Chao-Ming
    Horowitz, Sandra
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 361 - 373
  • [36] Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy
    Bossi, Elisa
    Aroldi, Andrea
    Brioschi, Filippo A.
    Steidl, Carolina
    Baretta, Silvia
    Renso, Rossella
    Verga, Luisa
    Fontana, Diletta
    Sharma, Geeta G.
    Mologni, Luca
    Mussolin, Lara
    Piazza, Rocco
    Gambacorti-Passerini, Carlo
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : E319 - E321
  • [37] Refractory or relapsed ALK-positive anaplastic T large cell lymphoma treated with crizotinib
    Miaomiao, L.
    Zhang, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1758 - 1758
  • [38] Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study
    Hess, Brian T. T.
    Giri, Anshu
    Park, Yeonhee
    Patel, Krina K. K.
    Link, Brian K. K.
    Nowakowski, Grzegorz S. S.
    Maliske, Seth M. M.
    Fortin, Sonia
    Chavez, Julio C. C.
    Saeed, Hayder
    Hill, Brian T. T.
    Mejia Garcia, Alex V. V.
    Maddocks, Kami J. J.
    Hanel, Walter
    Wagner-Johnston, Nina D. D.
    Messmer, Marcus R. R.
    Kahl, Brad S. S.
    Watkins, Marcus
    Alderuccio, Juan Pablo
    Lossos, Izidore S. S.
    Nathan, Sunita
    Orellana-Noia, Victor M. M.
    Portell, CraigA A.
    Landsburg, Daniel J. J.
    Ayers, Emily C. C.
    Castillo, Jorge J. J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (02) : 300 - 308
  • [39] CHARACTERISTICS AND OUTCOMES OF PEDIATRIC HEAT STROKE ADMISSIONS: A MULTI-INSTITUTIONAL ANALYSIS
    Hadad, Elit
    Puri, Kriti
    Wang, Yunfei
    Ruth, Amanda
    CRITICAL CARE MEDICINE, 2020, 48
  • [40] The Impact of Tracheostomy on Pediatric Heart Transplant Outcomes: A Multi-Institutional Analysis
    Spinner, J. A.
    Denfield, S. W.
    Puri, K.
    Morris, S. A.
    Moffett, B. S.
    Price, J. F.
    Dreyer, W. J.
    Cabrera, A. G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S23 - S24